ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19.
Saved in:
| Title: | ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19. |
|---|---|
| Authors: | Pietzner M; Computational Medicine, Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany. maik.pietzner@bih-charite.de.; MRC Epidemiology Unit, University of Cambridge, Cambridge, UK. maik.pietzner@bih-charite.de., Chua RL; Center for Digital Health, Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany., Wheeler E; MRC Epidemiology Unit, University of Cambridge, Cambridge, UK., Jechow K; Center for Digital Health, Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany., Willett JDS; McGill Genome Centre, McGill University, Montréal, QC, Canada.; Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada., Radbruch H; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt-Universität zu Berlin, Berlin, Germany., Trump S; Molecular Epidemiology Unit, Center for Digital Health, Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany., Heidecker B; Department of Cardiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt-Universität zu Berlin, Berlin, Germany., Zeberg H; Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.; Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden., Heppner FL; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt-Universität zu Berlin, Berlin, Germany.; Cluster of Excellence, NeuroCure, Berlin, Germany.; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany., Eils R; Center for Digital Health, Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Health Data Science Unit, Heidelberg University Hospital and BioQuant, Heidelberg, Germany.; German Center for Lung Research (DZL), associated partner site, Augustenburger Platz 1, 13353, Berlin, Germany., Mall MA; German Center for Lung Research (DZL), associated partner site, Augustenburger Platz 1, 13353, Berlin, Germany.; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany., Richards JB; McGill Genome Centre, McGill University, Montréal, QC, Canada.; Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada.; Departments of Medicine, Human Genetics, Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada.; Department of Twin Research, King's College London, London, United Kingdom., Sander LE; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany., Lehmann I; Molecular Epidemiology Unit, Center for Digital Health, Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Center for Lung Research (DZL), associated partner site, Augustenburger Platz 1, 13353, Berlin, Germany., Lukassen S; Center for Digital Health, Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany., Wareham NJ; MRC Epidemiology Unit, University of Cambridge, Cambridge, UK., Conrad C; Center for Digital Health, Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany. christian.conrad@bih-charite.de., Langenberg C; Computational Medicine, Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany. claudia.langenberg@bih-charite.de.; MRC Epidemiology Unit, University of Cambridge, Cambridge, UK. claudia.langenberg@bih-charite.de. |
| Source: | Nature communications [Nat Commun] 2022 Aug 15; Vol. 13 (1), pp. 4484. Date of Electronic Publication: 2022 Aug 15. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-022-31999-6 |
